Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker study
前瞻性评估免疫学、分子遗传学、影像学和微生物学分析在接受同步放化疗后序贯度伐利尤单抗巩固治疗的不可切除III期非小细胞肺癌患者中的肿瘤反应和控制特征(PRECISION):一项前瞻性纵向生物标志物研究方案
期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-21-1010
Käsmann, Lukas; Taugner, Julian; Eze, Chukwuka; Nieto, Alexander; Pelikan, Carolyn; Flörsch, Benedikt; Kenndoff, Saskia; Hofer, Thomas P; Nössner, Elfriede; Schulz, Christian; Unterrainer, Marcus; Tufman, Amanda; Klauschen, Frederick; Jung, Andreas; Neumann, Jens; Kumbrink, Jörg; Reinmuth, Niels; Bartenstein, Peter; Belka, Claus; Manapov, Farkhad